Nordea Investment Management AB Boosts Holdings in Pediatrix Medical Group, Inc. (NYSE:MD)

Nordea Investment Management AB boosted its holdings in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) by 51.6% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 263,633 shares of the company's stock after acquiring an additional 89,739 shares during the period. Nordea Investment Management AB owned 0.31% of Pediatrix Medical Group worth $3,504,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of MD. Quest Partners LLC raised its position in shares of Pediatrix Medical Group by 25.6% in the 3rd quarter. Quest Partners LLC now owns 3,054 shares of the company's stock worth $35,000 after purchasing an additional 622 shares during the last quarter. Quarry LP increased its stake in Pediatrix Medical Group by 54.1% during the 3rd quarter. Quarry LP now owns 4,735 shares of the company's stock valued at $55,000 after purchasing an additional 1,662 shares in the last quarter. Canada Pension Plan Investment Board purchased a new position in Pediatrix Medical Group in the second quarter worth about $72,000. CWM LLC lifted its stake in shares of Pediatrix Medical Group by 134.0% in the third quarter. CWM LLC now owns 6,427 shares of the company's stock worth $74,000 after buying an additional 3,681 shares in the last quarter. Finally, Vanguard Personalized Indexing Management LLC purchased a new stake in shares of Pediatrix Medical Group during the second quarter valued at approximately $81,000. Institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Stock Performance

Shares of Pediatrix Medical Group stock traded down $0.27 during trading hours on Friday, reaching $12.46. 396,100 shares of the stock traded hands, compared to its average volume of 427,728. The company has a 50 day moving average price of $14.30 and a 200 day moving average price of $11.60. Pediatrix Medical Group, Inc. has a one year low of $6.62 and a one year high of $16.41. The company has a quick ratio of 1.42, a current ratio of 1.42 and a debt-to-equity ratio of 0.83. The firm has a market capitalization of $1.07 billion, a price-to-earnings ratio of -4.07, a P/E/G ratio of 2.00 and a beta of 1.58.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last announced its earnings results on Friday, November 1st. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.07. The company had revenue of $511.20 million during the quarter, compared to analyst estimates of $498.87 million. Pediatrix Medical Group had a negative net margin of 12.65% and a positive return on equity of 12.79%. The firm's quarterly revenue was up .9% compared to the same quarter last year. During the same period in the previous year, the business posted $0.29 earnings per share. On average, equities research analysts expect that Pediatrix Medical Group, Inc. will post 1.26 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on MD shares. StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Thursday. Mizuho increased their price objective on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a "neutral" rating in a research report on Tuesday, November 19th. UBS Group boosted their target price on Pediatrix Medical Group from $10.50 to $16.50 and gave the stock a "neutral" rating in a research report on Tuesday, November 5th. Truist Financial dropped their price target on shares of Pediatrix Medical Group from $16.00 to $15.00 and set a "hold" rating on the stock in a report on Monday, January 6th. Finally, Macquarie started coverage on shares of Pediatrix Medical Group in a report on Monday, December 16th. They set an "outperform" rating and a $18.00 price objective for the company. Four research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $16.25.

Insider Buying and Selling

In other news, EVP Mary Ann E. Moore sold 8,108 shares of the stock in a transaction on Friday, November 8th. The shares were sold at an average price of $16.00, for a total value of $129,728.00. Following the completion of the sale, the executive vice president now directly owns 135,810 shares of the company's stock, valued at $2,172,960. This represents a 5.63 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Mark S. Ordan sold 27,600 shares of Pediatrix Medical Group stock in a transaction on Wednesday, November 13th. The shares were sold at an average price of $15.35, for a total transaction of $423,660.00. Following the transaction, the director now owns 138,683 shares in the company, valued at approximately $2,128,784.05. This trade represents a 16.60 % decrease in their position. The disclosure for this sale can be found here. 2.00% of the stock is owned by insiders.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.